Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Tumor stem cell research - basis and challenge for diagnosis and therapy].
Karlic H, Herrmann H, Schulenburg A, Grunt TW, Laffer S, Mirkina I, Hubmann R, Shehata M, Marian B, Selzer E, Pfeilstöcker M, Pittermann E, Jäger U, Pehamberger H, Zielinski C, Valent P. Karlic H, et al. Among authors: laffer s. Wien Klin Wochenschr. 2010 Jul;122(13-14):423-36. doi: 10.1007/s00508-010-1408-z. Epub 2010 Jul 22. Wien Klin Wochenschr. 2010. PMID: 20645015 Review. German.
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR, Zielinski CC, Valent P. Prager GW, et al. Among authors: laffer s. Mol Oncol. 2010 Apr;4(2):150-60. doi: 10.1016/j.molonc.2010.01.002. Epub 2010 Jan 7. Mol Oncol. 2010. PMID: 20106729 Free PMC article.
Neoplastic stem cells: current concepts and clinical perspectives.
Schulenburg A, Brämswig K, Herrmann H, Karlic H, Mirkina I, Hubmann R, Laffer S, Marian B, Shehata M, Krepler C, Pehamberger H, Grunt T, Jäger U, Zielinski CC, Valent P. Schulenburg A, et al. Among authors: laffer s. Crit Rev Oncol Hematol. 2010 Nov;76(2):79-98. doi: 10.1016/j.critrevonc.2010.01.001. Epub 2010 Feb 25. Crit Rev Oncol Hematol. 2010. PMID: 20185329 Review.
Trimolecular complex formation of IgE, Fc epsilon RI, and a recombinant nonanaphylactic single-chain antibody fragment with high affinity for IgE.
Lupinek C, Roux KH, Laffer S, Rauter I, Reginald K, Kneidinger M, Blatt K, Ball T, Pree I, Jahn-Schmid B, Allam JP, Novak N, Drescher A, Kricek F, Valent P, Englund H, Valenta R. Lupinek C, et al. Among authors: laffer s. J Immunol. 2009 Apr 15;182(8):4817-29. doi: 10.4049/jimmunol.0800726. J Immunol. 2009. PMID: 19342660
An in vitro model for the allergen-IgE-FcARI interaction.
Laffer S, Hogbom E, Adrianson J, Grönlund H, Sillaber C, Valent P, Vangelista L, Kricek F, Kraft D, Valenta R. Laffer S, et al. Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):116-8. doi: 10.1159/000024044. Int Arch Allergy Immunol. 1999. PMID: 10224355
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
Laffer S, Hogbom E, Roux KH, Sperr WR, Valent P, Bankl HC, Vangelista L, Kricek F, Kraft D, Grönlund H, Valenta R. Laffer S, et al. J Allergy Clin Immunol. 2001 Sep;108(3):409-16. doi: 10.1067/mai.2001.117593. J Allergy Clin Immunol. 2001. PMID: 11544461
45 results